LGND
Ligand Pharmaceuticals Incorporated
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $254M | +10.4% |
| Gross profit | $277M | +13.7% |
| Operating income | $24M | +1.8% |
| Net income | $51M | — |
| EPS | $2.21 | — |
| Free cash flow | $91M | −0.5% |